Advertisement
Advertisement

FBRX

FBRX logo

Forte Biosciences, Inc. Common Stock

24.66
USD
Sponsored
+0.37
+1.52%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

24.62

-0.04
-0.16%

Forte Biosciences, Inc. Common Stock Profile

About

Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.

Info & Links

CEO

Paul A. Wagner

Headquarters

3060 PEGASUS PARK DRIVE, BUILDING 6
DALLAS, TX 75247, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.fortebiorx.com

Auditor

KPMG LLP

Share holders

168

Employees

19

Forte Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

504.19M

Enterprise Value

445.97M

Enterprise Value/EBITDA(ttm)

-5.78

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.96

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-98.36%

Return on Invested Capital(ttm)

-86.81%

Return on Assets(ttm)

-82.81%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-77.14M

Net Income Available to Common(ttm)

-75.85M

Diluted EPS(ttm)

-4.77

Share Statistics

Beta (5Y Monthly)

3.20

52-Week Change

262.65%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

20.48M

Dividend Yield

0.00%

Float4

13.07M

% Held by Insiders

5.90%

% Held by Institutions

77.63%

Balance Sheet

Total Cash(mrq)

58.22M

Total Cash Per Share(mrq)

2.84

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.34%

Quick Ratio(mrq)

3.88%

Book Value Per Share(mrq)

6.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.93

Free Cash Flow(ytd)

-34.53M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement